Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Shen

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|May 5, 2001
Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disordersJ Nemec, W K Shen
Mayo Clinic Proceedings|March 1, 1995
Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiologyW K Shen, Y Kurachi
Expert Opinion on Pharmacotherapy|March 16, 2001
Pharmacotherapy of atrial fibrillationJ Nemec, W K Shen
Journal of Cardiovascular Electrophysiology|August 1, 1995
Bradycardia-induced polymorphic ventricular tachycardia after atrioventricular junction ablation for sinus tachycardia-induced cardiomyopathyR R Brandt, W K Shen
The American Journal of Geriatric Cardiology|March 20, 2001
Syncope in the elderly: new trends in diagnostic approach and nonpharmacologic managementD M Luria, W K Shen
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 1, 1991
Transesophageal echocardiography: detection of an acquired left ventricular-right atrial shuntW K Shen, B K Khandheria
The American Journal of Emergency Medicine|April 28, 2001
Amiodarone-induced long QT and polymorphic ventricular tachycardiaV T Nkomo, W K Shen
Clinical Pharmacology and Therapeutics|January 30, 2007
Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablationD J Bradley, W-K Shen
Mayo Clinic Proceedings|September 1, 1991
Survivors of acute myocardial infarction: who is at risk for sudden cardiac death?W K Shen, S C Hammill
Expert Opinion on Pharmacotherapy|February 5, 2002
Potassium channel openers: therapeutic potential in cardiology and medicineA Jahangir, A Terzic, W K Shen
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|May 5, 2001
Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disordersJ Nemec, W K Shen
Mayo Clinic Proceedings|March 1, 1995
Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiologyW K Shen, Y Kurachi
Expert Opinion on Pharmacotherapy|March 16, 2001
Pharmacotherapy of atrial fibrillationJ Nemec, W K Shen
Journal of Cardiovascular Electrophysiology|August 1, 1995
Bradycardia-induced polymorphic ventricular tachycardia after atrioventricular junction ablation for sinus tachycardia-induced cardiomyopathyR R Brandt, W K Shen
The American Journal of Geriatric Cardiology|March 20, 2001
Syncope in the elderly: new trends in diagnostic approach and nonpharmacologic managementD M Luria, W K Shen
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 1, 1991
Transesophageal echocardiography: detection of an acquired left ventricular-right atrial shuntW K Shen, B K Khandheria
The American Journal of Emergency Medicine|April 28, 2001
Amiodarone-induced long QT and polymorphic ventricular tachycardiaV T Nkomo, W K Shen
Clinical Pharmacology and Therapeutics|January 30, 2007
Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablationD J Bradley, W-K Shen
Mayo Clinic Proceedings|September 1, 1991
Survivors of acute myocardial infarction: who is at risk for sudden cardiac death?W K Shen, S C Hammill
Expert Opinion on Pharmacotherapy|February 5, 2002
Potassium channel openers: therapeutic potential in cardiology and medicineA Jahangir, A Terzic, W K Shen
Pageof 7